We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Pulsipher

Michael Allen Pulsipher MD

Professor of Pediatrics and Adjunct Professor of Medicine, University of Utah School of Medicine; Director, Pediatric Blood and Marrow Transplant Program, Primary Children’s Medical Center, Salt Lake City, Utah

Dr. Pulsipher completed medical school at Stanford University followed by pediatric residency training at the Children’s Hospital of Philadelphia and subspecialty fellowship training in hematology/oncology at the Dana Farber Cancer Institute/Children’s Hospital in Boston.  His first academic appointment was as an Instructor in Pediatrics at Harvard Medical School where he studied marrow failure disorders.  He accepted an appointment as an Assistant Professor at the University of Utah in 2000 and currently is a tenured Professor of Pediatrics.

Dr. Pulsipher is currently the Director of the Pediatric Blood and Marrow Transplant Program at Primary Children’s Medical Center, having served as the Director of the combined adult and pediatric Utah Blood and Marrow Transplant Program from 2005-2007 and as the Clinical Director of the adult BMT program, currently housed at the Huntsman Cancer Institute, from 2007-2009.

Dr. Pulsipher’s areas of research focus include innovative approaches to transplantation of children with acute lymphoblastic leukemia, reduced toxicity approaches to transplant, donor safety, and transplantation of nonmalignant disorders such as bone marrow failure diseases and immune deficiencies.  He has more than 100 publications and significant funding through the NIH, the St. Baldrick’s Foundation, and other private funding sources.  His research interests have led to national and international leadership roles in the Children’s Oncology Group, the Blood and Marrow Transplant Clinical Trials Network, the Center for International Blood and Marrow Transplant Research, and the Pediatric Blood and Marrow Transplant Consortium, of which he is currently the Group Chair.  Dr. Pulsipher also serves as one of 20 selected experts in pediatric oncology on the National Cancer Institute’s Pediatric Physician’s Data Query Board.

Recent Contributions to PracticeUpdate:

  1. Safety of Peripheral Blood Stem Cell vs Bone Marrow Donation